lobbying_activities: 2110040

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2110040	6dd5d93c-1371-405f-bcab-7f220671edfa	Q1	WAXMAN STRATEGIES	401103693	340B HEALTH	2018	first_quarter	PHA	Issues affecting the 340B drug pricing program; Pause Act	HOUSE OF REPRESENTATIVES,SENATE	18750		0	0	2018-04-18T12:01:19.267000-04:00